| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), MREO's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Fox Christine Ann65 | Chief Financial Officer | Sell | 28,286 | $4.30 | $121,692.72 | -24.1% | -12.9% | -56.8% | |
| Sep 13, 2024 | Hughes-Wilson Alexandra65 | See Remarks | Sell | 148,110 | $4.30 | $637,203.07 | -74.6% | -12.9% | -56.8% | |
| Sep 13, 2024 | Scots-Knight Denise65 | Chief Executive Officer | Sell | 88,657 | $4.30 | $381,422.59 | -9.9% | -12.9% | -56.8% | |
| Sep 13, 2024 | Lewicki John A.65 | Chief Scientific Officer | Sell | 16,149 | $4.30 | $69,476.79 | -17.0% | -12.9% | -56.8% | |
| Sep 13, 2024 | Sermon Charles65 | General Counsel | Sell | 30,926 | $4.30 | $133,050.61 | -12.4% | -12.9% | -56.8% | |
| Aug 22, 2024 | Pakianathan Deepika90 | Director | Sale+OE | 105,244 | $4.43 | $466,209.87 | -100% | -20.6% | -62.3% | |
| Jun 26, 2024 | Sermon Charles65 | General Counsel | Sell | 46,389 | $3.49 | $161,677.70 | -20.1% | +16.0% | -19.8% | |
| Jun 26, 2024 | Lewicki John A.65 | Chief Scientific Officer | Sell | 24,224 | $3.49 | $84,426.87 | -33.2% | +16.0% | -19.8% | |
| Jun 26, 2024 | Fox Christine Ann65 | Chief Financial Officer | Sell | 42,429 | $3.49 | $147,876.18 | -42.4% | +16.0% | -19.8% | |
| Jun 26, 2024 | Scots-Knight Denise65 | Chief Executive Officer | Sell | 132,985 | $3.49 | $463,486.80 | -15.8% | +16.0% | -19.8% |